Cord Blood Stem Cell TransplantationFetal BloodHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousMonocrotophosTransplantation, AutologousTransplantation ConditioningGraft vs Host DiseaseStem Cell TransplantationHematologic NeoplasmsPenile ImplantationStem CellsTransplantation ChimeraHematopoietic Stem CellsTissue DonorsBlood BanksHistocompatibility TestingTreatment OutcomeAntigens, CD34Hematopoietic Stem Cell MobilizationBone Marrow TransplantationGraft SurvivalMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyCell DifferentiationBusulfanMyeloablative AgonistsSpinal CordMultiple MyelomaRecurrenceCyclophosphamideBlood Component RemovalMice, SCIDKidney TransplantationHistocompatibilityAntineoplastic Combined Chemotherapy ProtocolsImmunosuppressive AgentsRemission InductionCells, CulturedWhole-Body IrradiationLiver TransplantationRetrospective StudiesLeukemiaLymphoma, Non-HodgkinTime FactorsSpinal Cord InjuriesAntineoplastic Agents, AlkylatingDisease-Free SurvivalMesenchymal Stem Cell TransplantationVidarabineHematopoiesisGraft vs Leukemia EffectInfectionSurvival RateSurvival AnalysisEtoposideCell TransplantationTransplantation, IsogeneicThiotepaHematologic DiseasesSalvage TherapyLeukemia, Myeloid, AcuteEmbryonic Stem CellsBlood CellsPOEMS SyndromeCytomegalovirus InfectionsAmyloidosisHLA AntigensHeart TransplantationGraft RejectionHodgkin DiseaseFollow-Up StudiesMyelodysplastic SyndromesMice, Inbred NODAdult Stem CellsAnemia, AplasticCytarabineUmbilical CordTransplantation ImmunologyFatal OutcomeImmunosuppressionVincristineCyclosporineLung TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphomaCarmustineLymphocyte Depletion